ES2192911A1 - Antisuero policlonal especifico contra el receptor p2y1, procedimiento para su obtencion y aplicaciones. - Google Patents
Antisuero policlonal especifico contra el receptor p2y1, procedimiento para su obtencion y aplicaciones.Info
- Publication number
- ES2192911A1 ES2192911A1 ES200002561A ES200002561A ES2192911A1 ES 2192911 A1 ES2192911 A1 ES 2192911A1 ES 200002561 A ES200002561 A ES 200002561A ES 200002561 A ES200002561 A ES 200002561A ES 2192911 A1 ES2192911 A1 ES 2192911A1
- Authority
- ES
- Spain
- Prior art keywords
- receptor
- polyclonal antiserum
- specific polyclonal
- terminal epitope
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Antisuero policlonal específico contra el receptor P2Y{sub,1}, procedimiento para su obtención y aplicaciones. El antisuero policlonal es específico contra el receptor P2Y{sub, 1}, en particular, contra un epítopo carboxi-terminal del receptor P2Y{sub,1}. Este antisuero es útil para la inmunolocalización de dicho receptor en una muestra biológica.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200002561A ES2192911B1 (es) | 2000-10-25 | 2000-10-25 | Antisuero policlonal especifico contra el receptor p2y1, procedimiento para su obtencion y aplicaciones. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200002561A ES2192911B1 (es) | 2000-10-25 | 2000-10-25 | Antisuero policlonal especifico contra el receptor p2y1, procedimiento para su obtencion y aplicaciones. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2192911A1 true ES2192911A1 (es) | 2003-10-16 |
ES2192911B1 ES2192911B1 (es) | 2005-04-01 |
Family
ID=29724666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200002561A Expired - Fee Related ES2192911B1 (es) | 2000-10-25 | 2000-10-25 | Antisuero policlonal especifico contra el receptor p2y1, procedimiento para su obtencion y aplicaciones. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2192911B1 (es) |
-
2000
- 2000-10-25 ES ES200002561A patent/ES2192911B1/es not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
MOORE, D. et al. "Regional and cellular distribution of the P2Y1 purinergic receptor in the human brain: Striking neuronal localisation". THE JOURNAL OF COMPARATIVE NEUROLOGY, Vol. 421, nö 3, 05.06.2000, páginas 374-384. Todo el documento. * |
MOR-N-JIM+NEZ, M.J. et al. "Immunohistochemical localization of the P2Y1 purinergic receptor in neurons and glial cells of the central nervous system". MOLECULAR BRAIN RESEARCH, Vol. 78, nö 1-2, 31.05.2000, páginas 50-58. Todo el documento. * |
Also Published As
Publication number | Publication date |
---|---|
ES2192911B1 (es) | 2005-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0300841A3 (en) | Agonist anti-trk-c monoclonal antibodies | |
EP1519747A4 (en) | HUMAN MONOCLONAL ANTIBODIES AGAINST PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) | |
RS20130234A1 (en) | Therapeutic human anti-il-1r1 monoclonal antibody | |
MA30345B1 (fr) | Formulation d'anticorps monoclonal humain anti-igf-1r | |
WO1999048523A3 (en) | Antagonists of the inflammatory mediator oncostatin m (osm) | |
DE60225673D1 (de) | Kappa-opioid-rezeptor-liganden | |
SG196835A1 (en) | Human anti-b7rp1 neutralizing antibodies | |
NO20054351L (no) | Monoklonalt antistoff og hybridom som produserer dette | |
PT973550E (pt) | Anticorpos antagonistas anti-integrina avb3 | |
GB0031527D0 (en) | New use | |
WO2002059280A3 (en) | Chronic lymphocytic leukemia cell line and its use for producing an antibody | |
MXPA03004030A (es) | Proceso para preparacion de antitrombina iii latente. | |
ATE404211T1 (de) | Xenon als nmda-antogonist zur neuroprotektion | |
EA200400455A1 (ru) | Способ приготовления быстрорастворимой дозировочной формы | |
MXPA02010147A (es) | Antagonistas cd40 para uso en el tratamiento de psoriasis y otras condiciones inflamatorias de la piel. | |
IL139217A0 (en) | Monoclonal antibodies to the human ldl receptor, their production and use | |
ES2192911A1 (es) | Antisuero policlonal especifico contra el receptor p2y1, procedimiento para su obtencion y aplicaciones. | |
ATE440945T1 (de) | Menschliche myelom zelllinie | |
FI980863A (fi) | Menetelmä juoman ylikuohuntatekijän määrittämiseksi | |
HUP9801938A3 (en) | Substituted phenyl compounds as endothelin antagonists, process for producing and use thereof | |
EP1621555A4 (en) | IMMUNOGENIC, COMPOSITION FOR IMMUNOLOGICAL USE AND METHOD FOR THE PRODUCTION OF ANTIBODIES WITH THEIR USE | |
ATE207935T1 (de) | Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid | |
HU0100948D0 (en) | Antibody competiton binding assay for qualitative detection of the conformation changes and conformation-dependent quantitative detection of glycoprotein p and other cell surface receptors, pumps and proteins, and use thereof | |
MXPA02009210A (es) | Modificacion amorfa de torasemida. | |
AU2001290801A1 (en) | Peptide epitopes recognized by antigen specific cd4+ t lymphocytes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20031016 Kind code of ref document: A1 |
|
FG2A | Definitive protection |
Ref document number: 2192911B1 Country of ref document: ES |
|
FD2A | Announcement of lapse in spain |
Effective date: 20210201 |